Search Results - "Ogar, Comfort"

The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs) by Elhawary, Mohamed A., Ogar, Comfort K., Tarapués, Mónica, Caro, Angela, Ndagije, Helen Byomire, Benabdallah, Ghita, Sefiani, Houda, Rostom, Hadir

“…Pharmacovigilance (PV) is a multi-sectoral discipline essential for achieving optimal outcomes for patients in the process of healthcare delivery. Individual…”
Get full text

Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study by Ogar, Comfort K., Quick, Jonathan, Gilbert, Hannah N., Vreman, Rick A., Mantel-Teeuwisse, Aukje K., Mugunga, Jean Claude

“…Introduction/Objective Rapid global approval of coronavirus disease 2019 (COVID-19) vaccines and concurrent introduction in high-income countries and low- and…”
Get full text

Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy by Regan, Annette K., Fell, Deshayne B., Wise, Lauren A., Vazquez-Benitez, Gabriela, Håberg, Siri E., Ogar, Comfort, Yland, Jennifer J., Wesselink, Amelia K., Zerbo, Ousseny

Get full text

Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study by Ogar, Comfort K., Gilbert, Hannah N., Bloem, Lourens T., Leopold, Christine, Bassi, Peter U., Katagum, Yahaya M., Osakwe, Adeline I., Opadeyi, Abimbola O., Oreagba, Ibrahim, Mbo, Danjuma N.D., Mantel-Teeuwisse, Aukje K., De Bruin, Marie L.

“…Adverse events following immunization (AEFIs), especially if serious, may impact vaccine recipients' quality of life and financial well-being and fuel vaccine…”
Get full text

Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study by Avong, Yohanna Kambai, Jatau, Bolajoko, Gurumnaan, Ritmwa, Danat, Nanfwang, Okuma, James, Usman, Istifanus, Mordi, Dennis, Ukpabi, Blessing, Kayode, Gbenga Ayodele, Dutt, Saswata, El-Tayeb, Osman, Afolabi, Bamgboye, Ambrose, Isah, Agbaji, Oche, Osakwe, Adeline, Ibrahim, Ali, Ogar, Comfort, Nosiri, Helga, Avong, Eunice B, Adekanmbi, Victor, Uthman, Olalekan, Abimiku, Alash'le, Oni, Yetunde O, Mensah, Charles Olalekan, Dakum, Patrick, Mberu, Kamau Edward, Ogundahunsi, Olumide A T

“…Adverse Drug Reactions (ADRs) are a major clinical and public health problem world-wide. The prompt reporting of suspected ADRs to regulatory authorities to…”
Get full text

Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017 by Oshikoya, Kazeem Adeola, Ogunyinka, Ibrahim Abayomi, Ogar, Comfort Kunak, Abiola, Abiodun, Ibrahim, Ali, Oreagba, Ibrahim Adekunle

“…Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCARs). There is scant literature on…”
Get full text

Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016 by Oreagba, Ibrahim A., Oshikoya, Kazeem A., Ogar, Comfort, Adefurin, Abiodun O., Ibrahim, Ali, Awodele, Olufunsho, Oni, Yetunde

“…Adverse drug reactions (ADRs) recorded in national pharmacovigilance databases in developed countries have been analyzed. However, adverse reactions to…”
Get full text

Impact of comorbidity on adverse drug reaction profile in a cohort of patients treated with Artemisinin combination therapies for uncomplicated malaria in Nigeria by Bassi, Peter U., Osakwe, Adeline I., Ogar, Comfort K., Elagbaje, Cassandra, Nwankwo, Biyaya B., Balogun, Sulayman T., Ntadom, Godwin N., Isah, Ambrose O.

“…Artemisinin‐based combination antimalarial therapy (ACTs), is still highly effective in uncomplicated falciparum malaria, however, there remain some concerns…”
Get full text

Protocol for active safety monitoring of a cohort of patients using a dolutegravir-based antiretroviral regimen in Mozambique by Mussá, Merana, Gaspar, Irénio, Namburete, Luisa, Sitoie, Tânia Vuyeya, Couto, Aleny, Paulino, Jamal Mario, Lemos, Abrao, Vilanculos, Stefia, Ogar, Comfort Kunak, Namburete, Denylson, Seni, Eunice Dias, Hafner, Tamara, Stergachis, Andy

“…IntroductionDolutegravir-based antiretroviral therapy (ART) is increasingly being used as the preferred first-line regimen for the treatment of HIV in…”
Get full text

A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016 by Ogar, Comfort Kunak, Abiola, Abiodun, Yuah, Daniel, Ibrahim, Ali, Oreagba, Ibrahim Adekunle, Amadi, Emmanuel C., Adeyeye, Mojisola Christianah, Oshikoya, Kazeem Adeola

“…Background Adverse drug reactions (ADRs) are a source of concern in healthcare as they negatively affect patients. Serious adverse drug reactions (SADRs) have…”
Get full text

Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Lowand Middle-Income Countries: A Mixed Methods Study by Ogar, Comfort K, Quick, Jonathan, Gilbert, Hannah N, Vreman, Rick A, Mantel-Teeuwisse, Aukje K, Mugunga, Jean Claude

“…Introduction/Objective Rapid global approval of coronavirus disease 2019 (COVID-19) vaccines and concurrent introduction in high-income countries and low- and…”
Get full text

Safety of mRNA COVID-19 vaccines among persons 15- years and above in Ghana: A cohort event monitoring study by Darko, Delese Mimi, Seaneke, Seth Kwaku, Karikari-Boateng, Eric, Nkansah, Edwin, Amponsa-Achiano, Kwame, Mohamed, Naziru Tanko, Bonful, Harriet Affran, Buabeng, Richard Osei, Ashie, Adela, Asamoa-Amoakohene, Abena, Ewudzie-Sampson, Jeremiah, Derizie, Alexander Mwinteru, Neimatu, Adjabui D., Wilfred, Agongo A., Ogar, Comfort, Hagos, Aida, Sabblah, George Tsey

“…The development of COVID-19 vaccines during the pandemic occurred with an unprecedented speed, requiring extraordinary post-approval safety monitoring to…”
Get full text

Pharmacovigilance Rapid Alert System for Consumer Reporting (PRASCOR): A Look at Its Quantitative Contribution to Spontaneous Reporting in Nigeria from August 2012 to February 2017 by Ogar, Comfort Kunak, Ibrahim, Ali, Osakwe, Adeline Ijeoma, Jajere, Fatima, Kigbu-Adekunle, Ashega Ademulegun, Alonge, Kemi, Oni, Yetunde

“…Background Direct patient reporting (DPR) is a system where patients report suspected adverse drug reactions (ADRs) directly to competent bodies. Studies have…”
Get full text